Related Experiment Videos
Monoamine oxidase inhibitors and elective surgery
Z Y Ebrahim1, J O'Hara, L Borden
1Department of General Anesthesia, Cleveland Clinic Foundation, OH 44195.
Cleveland Clinic Journal of Medicine
|March 1, 1993
Summary
Monoamine oxidase inhibitor use, like isocarboxazid, is often avoided for elective surgery. This study reviewed 32 patients on isocarboxazid who underwent surgery, detailing their anesthetic management and outcomes.
Area of Science:
- Anesthesiology
- Pharmacology
- Surgical Care
Background:
- Monoamine oxidase inhibitors (MAOIs) are frequently contraindicated for elective surgical procedures.
- Concerns exist regarding potential drug interactions and adverse events during anesthesia in patients taking MAOIs.
Purpose of the Study:
- To evaluate the anesthetic management and postanesthesia outcomes of patients undergoing elective surgery while on a daily regimen of isocarboxazid.
- To describe the pharmacological considerations for managing patients on isocarboxazid during the perioperative period.
Main Methods:
- Retrospective review of 32 patients receiving isocarboxazid 10 mg daily who underwent elective surgery.
- Analysis of anesthetic techniques, intraoperative monitoring, and postanesthesia recovery data.
- Pharmacological assessment of isocarboxazid's role in perioperative management.
Main Results:
- Detailed description of anesthetic management strategies employed in the 32 patients.
- Assessment of postanesthesia outcomes, including complications and recovery trajectories.
- Discussion of the pharmacological profile of isocarboxazid in the context of surgery.
Conclusions:
- Elective surgery can be safely performed in patients on a stable regimen of isocarboxazid with appropriate anesthetic management.
- Perioperative outcomes for patients on isocarboxazid require careful consideration of MAOI pharmacology.
- Further research may elucidate optimal anesthetic protocols for MAOI users.